THREE PATHS TO REVENUE
There’s more than one way to work with ODT.
Our tablets use oromucosal, or buccal, absorption: the drug crosses the lining of the cheek directly into the bloodstream. That’s different from a swallowed tablet, chew, or oral film, all of which still have to survive digestion before they can work. Ours doesn’t have to survive anything. It’s absorbed before digestion even starts.
How we work with you
Working with ODT looks different depending on who you are.
THE DETAILS
One asset at a time, cleanly.
Seven animal-health-specific patents, layered on a platform protected by more than 20 issued patents across more than 60 countries. An organization structured to protect each product & opportunity. The practical effect is that a single program can be advanced on its own, without acquiring the platform, and without disturbing manufacturing or the other programs in development. Most companies at this stage cannot offer that.
Sometimes we look like a contract manufacturer, sometimes like a biotech, sometimes like a co-investor. The model flexes to what you are bringing. What does not flex is that manufacturing stays with us in all three. Most companies fit more than one of these, and the shape usually comes out of the first real conversation rather than the first meeting.
Capacity for fully outsourced development work is limited to a small number of concurrent programs. The earlier we talk, the more of it is open.
Real animals. Real administration. Not staged.
We’re building a library of real, unscripted administration footage across dogs, cats, and horses, filmed by our own team, friends, and family, not actors or stock talent. As it grows, you’ll find it here.
Manufacturing credibility
For the people who need the data, not the story.
Formulation scientists and technical diligence teams can request our full technical backgrounder, covering manufacturing specifications, stability data, and preclinical results.
The earlier we talk, the more options are open.
We’re deliberately selective about which molecules we take on. We’re not chasing generic, low-differentiation actives. Every program is chosen because the delivery problem is real and the format actually solves it.
Capacity for fully outsourced development work is limited to a small number of concurrent projects at a time.